The sinus dilation devices market is projected to experience notable growth during the forecast period, due to the increasing prevalence of chronic sinusitis, growing adoption of minimally invasive surgeries, technological advancements in sinusitis treatment, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario.

Based on product, the Sinus Dilation Devices market has been categorized into balloon dilation, stents, and endoscopes, where the balloon dilation devices hold the largest share in the market, owing to the increasing use of this device for dilating the sinus ostia through a minimally invasive approach.

The growing adoption of minimally invasive surgeries and technological advancements in sinusitis treatment are additional factors contributing to the growth of the sinus Dilation Devices Market. However, high risk of sinus surgeries and low adoption of the sinus treatment hampers the growth of the industry.

Increasing transformation of healthcare infrastructure in developing economies has emerged as an opportunity for the market players in the sinus dilation devices industry. According to the National Institute of Allergy and Infectious Diseases (NIAID), the prevalence of chronic sinusitis is more than diabetes, asthma, or coronary heart disease in the Indian population. In addition to this, the disease has high prevalence in urban areas due to high levels of pollution, unhealthy lifestyle, and congested living conditions of the urban population.

North America held the largest sinus dilation devices market share in 2017. The North American market is primarily driven by the growing adoption of minimally invasive surgeries and increasing prevalence of chronic sinusitis. The presence of government reimbursement policies and advanced healthcare facilities are additional factors of market growth in this region.

According to the American Society of Plastic Surgeons (ASPS), in 2017, around 17.5 million surgical and minimally invasive cosmetic procedures were performed in the U.S. During the forecast period, the market is expected to register the fastest growth in Asia-Pacific. The expected growth can be attributed to the increasing private and public healthcare expenditure and rising chronic sinusitis in developing countries.

Some of the key players of the sinus dilation devices industry includes Accurate Surgical & Scientific Instruments Corporation, Entellus Medical Inc., Medtronic plc, SinuSys Corporation, Sklar Surgical Instruments, Smith & Nephew plc, Meril Life Sciences Pvt. Ltd., dalENT Medical, and InnAccel Technologies.